Arbutus Biopharma ABUS
NASDAQ ABUS
$4.18 -0.15 (-3.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Debt Ratio (2016 - 2017)

Updated

Arbutus Biopharma's (ABUS) Debt Ratio stood at 0.05 in Q4 2017, up 16.3% from 0.04 a year earlier and up 1.1% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Debt Ratio (2016 - 2017) Analysis & Trends

Starting with Q4 2016, Arbutus Biopharma's Debt Ratio history includes 5 quarters.

  • Across earlier years, Debt Ratio came in at 0.04 in FY2016.
  • Per Business Quant, the preceding three quarters came in at 0.05 (Q3 2017), 0.05 (Q2 2017) and 0.04 (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Arbutus Biopharma 826.41 Mn 453.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 0.05
Sep 30, 2017 0.05
Jun 30, 2017 0.05
Mar 31, 2017 0.04
Dec 31, 2016 0.04
API Access

Arbutus Biopharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ABUS&period=max&api_key=YOUR_API_KEY